COYA – coya therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Coya Therapeutics, Inc.'s (NASDAQ:COYA) largest shareholders are retail investors with 60% ownership, insiders own 16% [Yahoo! Finance]
Coya Therapeutics, Inc. (NASDAQ: COYA) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $14.00 price target on the stock.
Coya Therapeutics Provides a Corporate Update and Reports Unaudited First Quarter 2024 Financial Results [Yahoo! Finance]
Coya Therapeutics Provides a Corporate Update and Reports Unaudited First Quarter 2024 Financial Results
Why Coya Therapeutics Is A Smart Speculative Buy For Neurodegenerative Diseases [Seeking Alpha]
Form 10-Q Coya Therapeutics, Inc. For: Mar 31
Form 8-K Coya Therapeutics, Inc. For: May 09
Form 8-K Coya Therapeutics, Inc. For: May 08
Form DEFA14A Coya Therapeutics, Inc.
Form ARS Coya Therapeutics, Inc. For: Dec 31
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.